Fig. 2From: Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to TherapyCancer therapy can strongly influence the metabolic reprogramming of resistant cancer cell subpopulations. They can rewire their metabolism towards glycolysis or OXPHOS on the basis of the type of cancer therapyBack to article page